Baolingbao Biology Co.,Ltd. (SHE:002286)
China · Delayed Price · Currency is CNY 8.75
+0.80 (10.06%)
Sep 23, 2026, 3:04 PM CST
Baolingbao Biology Market Cap
Baolingbao Biology has a market cap or net worth of 3.32 billion as of September 23, 2026. Its market cap has decreased by -8.51% in one year.
Market Cap
3.32B
Enterprise Value
3.20B
Revenue
2.85B
Ranking
n/a
PE Ratio
23.03
Stock Price
8.75
ChartMarket Cap Chart
Since August 28, 2009, Baolingbao Biology's market cap has increased from 1.81B to 3.32B, an increase of 84.04%. That is a compound annual growth rate of 3.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 3.32B | -2.28% |
| Dec 31, 2025 | 3.40B | 24.68% |
| Dec 31, 2024 | 2.73B | -9.36% |
| Dec 29, 2023 | 3.01B | -10.92% |
| Dec 30, 2022 | 3.38B | -32.78% |
| Dec 31, 2021 | 5.03B | 19.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Bioperfectus Technologies | 3.30B |
| Qingdao Vland Biotech INC. | 3.25B |
| Hinova Pharmaceuticals | 3.07B |
| Beijing Kawin Technology Share-Holding | 3.05B |
| Guanhao Biotech | 2.98B |
| Zhejiang Shouxiangu Pharmaceutical | 2.96B |
| Zhejiang East Asia Pharmaceutical | 2.78B |
| Guangdong VTR Bio-Tech | 2.76B |